enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lorcaserin - Wikipedia

   en.wikipedia.org/wiki/Lorcaserin

   Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals.It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus, a region of the brain which is known to control appetite. [6]

3. 25 Belt-Busting Obesity Facts - AOL

   www.aol.com/2013/05/18/25-belt-busting-obesity-facts

   The Food and Drug Administration approved the weight-loss therapy Belviq from Arena Pharmaceuticals in June 2012. It took nearly one year for the company to gain marketing approval, but Belviq's ...

4. New Obesity Drug Hits the Market - AOL

   www.aol.com/news/2013-06-07-new-obesity-drug...

   For premium support please call: 800-290-4726 more ways to reach us

5. 5 new weight-loss drugs to watch in the fight for the next ...

   www.aol.com/5-weight-loss-drugs-watch-104701179.html

   GLP-1 medications are breakthroughs for weight loss, diabetes, and more. Pharma companies are clamoring to produce pills or longer-lasting drugs with faster effects. Novo Nordisk, Eli Lilly ...

6. The Long Wait for This Obesity Drug Is Almost Over - AOL

   www.aol.com/news/2013-05-23-the-long-wait-for...

   It's been a long road, but Eisai and Arena Pharmaceuticals' obesity drug Belviq can finally launch in 30 days. The Drug Enforcement Agency has made its final ruling, assigning a Schedule IV ...

7. Are Obesity Drugs a Lost Cause in Europe? - AOL

   www.aol.com/news/2013-05-05-are-obesity-drugs-a...

   The company is waiting on DEA scheduling before it can start selling its obesity drug, Belviq. However, there's one place Belviq isn't going on sale Are Obesity Drugs a Lost Cause in Europe?